Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 12.11
1.94 %
$ 767 M
Market Cap
-13.31
P/E
Price Target
Average
81.67%
Revenue Forecast
Estimate
35.87%
EBIT
Estimate
--72.02%
Net Income
Estimate
43.70%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Evolus, Inc.
Wall Street analysts predict an average 1-year price target for EOLS of $22 , with forecasts ranging from a low of $16 to a high of $27 .
EOLS Lowest Price Target
Wall Street Target
16 USD
32.12%
EOLS Average Price Target
Wall Street Target
22 USD
81.67%
EOLS Highest Price Target
Wall Street Target
27 USD
122.96%
REVENUE FORECAST
Revenue Forecast Chart EOLS
EBIT FORECAST
EBIT Forecast Chart EOLS
NET INCOME FORECAST
Net Income Chart EOLS